Singular Genomics Systems Inc (OMIC) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Singular Genomics Systems Inc   (NASDAQ: OMIC)


Singular Genomics Systems Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Singular Genomics Systems Inc's ROI in the third quarter of 2024?
Singular Genomics Systems Inc recorded a cumulative net loss of $-86 million during 12 months ending in the third quarter of 2024, resulting in a negative return on investment (ROI) of -55.05%.

Within the Healthcare sector 473 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2024 from 3494 to 3615.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM -34.81 % -31.92 % -29.18 % -26.55 % -24.52 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 129 145 165 189 210
Return On Investment (TTM) -55.05 % -51.91 % -48.54 % -43.13 % -38.53 %
OMIC's Overall Ranking # 3615 # 3494 # 0 # 0 # 166
Seq. Investment Change TTM -11.42 % -10.68 % -9.84 % -8.61 % -7.5 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -86 -92 -96 -95 -93

OMIC Company Profile >> Back to OMIC Roi Comparisons >> See Annual OMIC Return On Investment



Return On Investment OMIC's Ranking
Within: No.
Industry # 21
Sector # 474
Overall # 3615

Return On Investment Statistics
High Average Low
31.1 %
-7.58 %
-41 %
(Sep 30 2023)   (Sep 30 2024)







Financial Statements
Singular Genomics Systems Inc's III. Quarter Investments $ 129 Millions OMIC's Balance sheet
Singular Genomics Systems Inc's III. Quarter Income $ -17 Millions Quarterly OMIC's Income Statement
OMIC's Income by Division See OMIC's Income by Division


OMIC Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021

Total Investments in Millions 189 271 349 0 0
Y / Y Investment Growth -30.52 % -22.21 % - - -
Net Income in Millions -95 91 -99 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -50.29 % 33.49 % -28.31 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OMIC's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OMIC's Competitors
Subscribers only: Roi for Singular Genomics Systems Inc's Suppliers
Subscribers only: Return On Investment for OMIC's Customers

Other Ratios
OMIC's Roa OMIC's Inventory Turnover Ratio OMIC's Growth Rates OMIC's Dividend Statistics
OMIC's Profitability Ratios OMIC's Asset Turnover Ratio OMIC's Dividend Growth
OMIC's Roe OMIC's Valuation Ratios OMIC's Financial Strength Ratios OMIC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.